Celsion CorpAdd to My Watchlist

CLSN:USNASDAQ CMIndustry: Medical-Biomedical/Gene
  • 2.63
    Last
  • 0.17  -6.08%
    Today's Change
  • 2.80
    Previous Close
  • Today
     
    2.15
    3.73
    52 Week Low - High
8:10 pm ET 5/22/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding20 million
Market Cap$53 million
Return on Equity ttm-79.24%
Last DividendCLSN:US does not pay a dividend
Earnings
EPS: Year Actual ttm-1.350
EPS: Year Est. 12/15 ttm-1.270
 
EPS: Quarterly Actual 3/15 -0.34
EPS: Quarterly Est. 6/15 -0.34
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-45.26
Company Description
Celsion Corporation is a development company specializing in heat based treatments for cancer and other diseases. The Company's products include a heat activated liposomal form of doxorubicin for the treatment for liver and breast cancers.
Revenue$500,000
Net Income$-25 million
Total Assets$67 million
Employees28
Web Sitewww.celsion.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!